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Histologically, three main subtypes have been
described including tracheobronchial, diffuse
alveolar septal amyloidosis, and nodular pulmonary (NPA).4 Of these types, NPA and tracheobronchial are typically confined to the
lung with NPA being the most common form
accounting for about half of reported cases.
NPA is typically of the AL type and can be associated with a polyclonal lymphoplasmacystic
infiltrate, though rare monoclonal types with
multiple lesions have been reported.5-10
Herein we report two clinical cases of monoclonal nodular pulmonary amyloidosis including one with a previously unreported presentation of a single, dominant lesion in addition to
a review of the literature.

Case Report
Case #1
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Introduction

Amyloidosis is a disease that results from
tissue deposition of abnormally folded protein.
To date, more than 30 different types of amyloid have been described, which all share the
morphologic characteristics of fibrillar betapleated sheet configuration.1 The most common type of amyloid is derived from
immunoglobulin light chain (AL) and usually
presents as a systemic disease, commonly
involving the kidneys, liver and spleen.2
Localized amyloid deposition can be organ specific where amyloid precursor is normally produced by the organ, or amyloid (most frequently AL amyloid) may deposit in a non-specific
localized form, confined to a specific organ
system.3 Amyloidosis involving the lung can be
divided broadly into cases associated with systemic amyloidosis or those restricted to localized pulmonary anatomy.
Localized pulmonary forms are most often
found to contain of kappa or lambda AL.
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A 76 year-old male presented with severe
aortic valve stenosis with symptoms of dyspnea
on mild exertion and ostial LAD stenosis confirmed by cardiac catheterization. At this time,
he was known to have bilateral pulmonary nodules in all lung lobes. By CT imaging, these
were suspicious for nodular pulmonary amyloi-
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Nodular pulmonary amyloidosis (NPA) is an
uncommon pathology of insoluble protein
depositing in pulmonary parenchyma. This
localized pulmonary form of amyloidosis is
most often found to contain combinations of
kappa and lambda immunoglobulin light chain
and immunoglobulin heavy chain proteins
with a polyclonal lymphoplasmacystic infiltrate. Herein we present two cases of NPA of
the rarely reported monoclonal (light-chain
restricted) form with review of the literature
and discussion of the clinical, radiographic,
and histologic features of NPA.

Key words: Pulmonary nodule; Amyloidosis;
Immunoglobulin.

A 55 year-old male with a chronic non-productive cough and 20 pack-year smoking history was referred to the surgical service with CT
finding of a 1.4 cm spiculated nodule in the
right middle lobe of his lung adjacent to the
visceral pleura. PET scan showed moderate
avidity with SUV of 4.2. CT-guided percutaneous lung biopsy revealed non-diagnostic
aspirate of rare atypical cells. Physical exam
revealed no neurologic dysfunction. Liver function tests and creatinine clearance were normal. Cardiac MRI demonstrated an interventricular septum (IVS) of 8 mm, ejection fraction (EF) of 75%, and normal left ventricular
(LV) mass for age and gender (56.2 g/m2).
There was also no evidence of late gadolinium
enhancement to suggest cardiac amyloid.
Thoracoscopic wedge biopsy and mediastinal lymph node dissection were obtained
which identified a 2.2 cm lesion consistent
with a localized pulmonary amyloidoma. The
wedge resection demonstrated a firm, homogenous dry grey-white mass puckering the pleura (2.2x1.5x1.0 cm). Histologically, the lesion
was a circumscribed nodule with acellular,
amorphous eosinophilic material filling the
alveolar spaces and foci of osteoid metaplasia.
Multinucleated giant cells and a mature
appearing lymphoplasmacytic infiltrate were
present, most notably at the edge of the lesion.
On Congo-Red stain, the material had a
salmon-colored appearance which showed
apple-green birefringence under polarized
light. Immunohistochemical stains revealed
lambda light chain restriction of the plasma
cells (Figure 1). The final diagnosis was pulmonary amyloidoma with osteoid metaplasia.
Mediastinal lymph nodes showed no significant histopathologic abnormality.
Serum protein electrophoresis showed
hypoalbuminemia but was otherwise unre-
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markable. Urine protein electrophoresis was
normal. Repeat serum protein electrophoresis
was essentially normal with no evidence of
monoclonal gammopathy. Serum free lambda
light chains were within normal limits. Free
kappa light chains were slightly elevated but
the kappa to lambda ratio was within the reference range. AA amyloid was negative by
immunostain. Abdominal fat pad aspirate was
performed to rule out systemic amyloidosis
with negative result. Of note, only Kappa and
Lambda antibodies are available in our laboratory. These immunostains were done to
demonstrate clonality of the surrounding plasmacytic infiltrates. Because of the high background, use of these antibodies is limited to
characterize the nature of the amyloid.

Case #2

Case Report
bone marrow biopsy with flow cytometry. In
addition, of particular concern is the assessment for systemic disease resulting in major
end organ damage (i.e. cardiac, liver, kidney,
or nervous system dysfunction.) Assessment of
cardiac function by echocardiography, scintigraphy, or magnetic resonance has become
standard as cardiac involvement is the major
determinant of long-term outcomes. While
amyloidosis is seen with some frequency in
clinical practice, NPA is less common.
Particularly of the popyclonal type, approximately one hundred cases have been reported
in the literature of NPA (Table 1).3,5-17 NPA is
typically of the AL variant, specifically lambda
light chain despite the usual association of AL
amyloid with systemic amyloidosis.2-4,15 The
amyloid is speculated to arise from a reaction
to chronic inflammatory conditions of the lung,
including connective tissue disorders, tuberculosis, or HIV infection. In keeping with this
presumptive origin, pulmonary amyloidoma is
thus usually associated with a polyclonal lymphoplasmacytic infiltrate at its periphery.15
Nine cases, including our two recent cases,
have been reported of otherwise histologically
typical pulmonary amyloidomas being associated with a monoclonal lymphoplasmacytic
infiltrate.18-23 Of these cases, age ranges from
55 to 73 with male predominance (7 of 9
cases). All cases demonstrated multifocal
lesions with the exception of our new case
presentation (Case 1). The relevant information from these cases is listed in Table 2. Given
the rarity of this pathologic type, its significance is not well understood.
Nodular pulmonary amyloidoma with associated monoclonal plasmacytic infiltrate, a localized amyloid, is thus a rare entity. It is radiographically and morphologically identical to
nodular pulmonary amyloidoma without light

green birefringence confirming the presence
of amyloid. Immunohistochemistry showed
CD138+ plasma cell infiltration with
kappa/lambda light chain antibodies binding at
a kappa restricted ratio of 100:1, indicating a
monoclonal population. On serum protein electrophoresis, the patient was found to have a
faint monoclonal band. Serum and urine free
light chains were minimal and within a normal
ratio. Bone marrow biopsy demonstrated an
atypical plasma cell infiltrate (8% plasma
cells), however it did not meet criteria for plasma cell dyscrasia. Bone marrow biopsy also
showed no evidence of amyloid. These findings
granted the diagnosis of monoclonal gammopathy of undetermined significance.
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Amyloidosis can be particularly difficult to
diagnose because workup involves imaging,
blood, and urine studies – none of which alone
are diagnostic. Proper assessment of the amyloid involves typing the protein deposits by
immunohistochemical
(IHC)
staining,
immunogold electron microscopy, or mass
spectrometry.11 Typing of the amyloid is ideal
but is available only in highly specialized institutions. Congo red stain confirms the presence
of amyloid. Staining for lambda and kappa
light chains to assess clonality should be done,
but clonality is not necessarily associated with
systemic disease. Serum and urine protein
analysis is necessary to exclude an underlying
or concurrent amyloid producing plasma cell
dyscrasia or lymphoma. Plasma cell dyscrasia
work up includes serum protein electrophoresis, serum free light chain assays, serum and
urine immunofixation electrophoreses, and
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dosis given their shape, pattern of calcification, and stability in size. Echocardiogram
found preserved LVEF of 55% and no visualized
myocardial deposits. The IVS measured at 0.98
cm with no evidence of diastolic function.
Pulmonary function testing was normal, and
the patient had no history of smoking.
Repeat CT scan of the chest without contrast revealed multiple bilateral lung nodules
in all lung lobes with irregular calcifications
with associated septal thickening suggestive
of amyloid infiltration. Bilateral hilar and
mediastinal lymphadenopathy were slightly
increased in size from previous CT a year
prior, however, lung nodules were unchanged.
PET scan showed these lesions to have standardized uptake values ranging from 2.3-5.8
SUV. In addition, there was radiotracer uptake
in bilateral paratracheal, hilar, prevascular,
and subcarinal lymph nodes ranging from 3.64.5 SUV.
Transbronchial biopsies of bilateral hilar
lymph nodes as well as right upper and middle
lobe masses were non-diagnostic, thus left
upper lobe wedge resection was performed at
the time of aortic valve replacement and coronary artery bypass grafting. Histology was consistent with amyloidosis. The lung parenchyma contained yellow brittle nodules with gross
central calcification. Light microscopy identified a deposit of eosinophilic homogenous
material with giant cell foreign body reaction
on hematoxylin and eosin stain. Congo Red
staining under polarized light revealed apple-

Table 1. Reported cases of pulmonary amyloidoma with associated polyclonal lymphoplasmacytic reaction.

Figure 1. Immunohistochemistry for
kappa (A) and lambda (B) light chains
reveals lambda light change restriction of
the plasma cells (original magnifications
x200).
[page 14]

Reference

Average age (range)

Sex (M:F)

Size (cm)

Number of cases

Hui
Thompson
da Costa
Pitz
Utz
Smith
Cordier
Dacic
Kawashima
Podbielski
Desai
Pusztaszeri
Asad

64
NR
49 (28-59)
48
67 (43-78)
79 (74-87)
NR
55 (25-65)
75
65
59 (48-69)
72
72

NR
NR
3:3
1:0
NR
2:1
2:0
3:3
0:1
0:1
1:1
0:1
0:1

1-4
1-15
2-7
NR
NR
.5-2
1-3.5
NR
NR
2
NR
5
NR

28
55
6
1
7
3
2
6
1
1
1
1
1

NR, not reported.
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Table 2. Reported cases of pulmonary amyloidoma with associated monoclonal light
chain lymphoplasmacytic reaction.
Reference

Age

Sex

Size (cm)

Number of lesions

Light chain

Original case
Original case
Miyamoto
Ross
Ross
Ihing
Ihing
Davis
Murata

55
76
72
60
73
67
66
56
63

M
M
M
F
F
M
M
M
M

2.2
1.5-9.3
0.9-3.5
0.7-2
NR
2.5
3
1.5
NR

Single
Multiple
Multiple
Multiple
Multiple
Multiple
Multiple
Multiple
Multiple

Lambda
Kappa
Kappa
NR
NR
Lambda
Lambda
Kappa
Kappa

10.

11.

12.

NR, not reported.
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Conclusions
Nodular pulmonary amyloidoma with associated monoclonal plasmacytic infiltrate is a rare
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entity. Proper radiographic, histologic, and IHC
workup can identify these lesions with particular attention to exclusion of systemic disease
and associated malignancy to identify those
patients who will benefit from directed treatment strategies.
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